{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T19:20:24Z","timestamp":1700248824065},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":7206,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1023\/a:1008328207137","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T09:41:38Z","timestamp":1040550098000},"page":"445-450","source":"Crossref","is-referenced-by-count":15,"title":["Phase II study of concurrent chemotherapy and radiotherapy for unresectable stage III non-small-cell lung cancer: Long-term follow-up results. Japan Clinical Oncology Group Protocol 8902"],"prefix":"10.1016","volume":"11","author":[{"given":"K.","family":"Kubota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Furuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008328207137_bb0005","first-page":"105","article-title":"Non-small-cell lung cancer. Part II: Treatment","volume":"15","author":"Ihde","year":"1991","journal-title":"Curr Prob Cancer"},{"key":"10.1023\/A:1008328207137_bb0010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/1097-0142(19820915)50:6<1091::AID-CNCR2820500612>3.0.CO;2-0","article-title":"Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-small-cell lung carcinoma: Report by the Radiation Therapy Oncology Group","volume":"50","author":"Perez","year":"1982","journal-title":"Cancer"},{"key":"10.1023\/A:1008328207137_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jnci\/83.6.417","article-title":"Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients","volume":"83","author":"Le Chevalier","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008328207137_bb0020","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199202203260805","article-title":"Effects of concomitant cisplatin and radiotherapy on inoperable non-smallcell lung cancer","volume":"326","author":"Schaake-Koning","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008328207137_bb0025","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.1995.13.2.452","article-title":"Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage HI non-small-cell lung cancer","volume":"13","author":"Jeremic","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008328207137_bb0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1200\/JCO.1996.14.4.1065","article-title":"Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin-etoposide for stage III non-small-cell lung cancer: A randomized study","volume":"14","author":"Jeremic","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008328207137_bb0035","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1056\/NEJM199010043231403","article-title":"A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer","volume":"323","author":"Dillman","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008328207137_bb0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jnci\/84.1.58","article-title":"Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung cancer (Letter)","volume":"84","author":"Le Chevalier","year":"1992","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008328207137_bb0045","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/88.17.1210","article-title":"Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial","volume":"88","author":"Dillman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1008328207137_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/0360-3016(95)97772-S","article-title":"RTOG 8808 ECOG 4588, Preliminary analysis of a phase III trial in regionally advanced unresectable non-small-cell lung cancer with minimum three-year follow-up","volume":"32","author":"Sause","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008328207137_bb0055","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.1994.12.8.1547","article-title":"Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer","volume":"12","author":"Kubota","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008328207137_bb0060","series-title":"WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48","year":"1979"},{"key":"10.1023\/A:1008328207137_bb0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1023\/A:1008328207137_bb0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0360-3016(97)00365-9","article-title":"Induction cisplatinvinblastine and irradiation versus irradiation in unresectable squamous-cell lung cancer: Failure patterns by cell type in RTOG 88-08\/ECOG 4588","volume":"39","author":"Komaki","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1023\/A:1008328207137_bb0075","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1200\/JCO.1996.14.4.1055","article-title":"Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group Protocol 91-06","volume":"14","author":"Lee","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008328207137_bb0080","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.1995.13.4.869","article-title":"Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer","volume":"13","author":"Furuse","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008328207137_bb0085","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1002\/1097-0142(19950501)75:9<2337::AID-CNCR2820750924>3.0.CO;2-K","article-title":"Concurrent hyperfractionated irradiation and chemotherapy for unresectable non-small-cell lung cancer","volume":"75","author":"Byhardt","year":"1995","journal-title":"Cancer"},{"key":"10.1023\/A:1008328207137_bb0090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients","volume":"12","author":"Le Chevalier","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008328207137_bb0095","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/oxfordjournals.annonc.a010760","article-title":"Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage HIB or IV non-small-cell lung cancer (NSCLC)","volume":"7","author":"Furuse","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1008328207137_bb0100","first-page":"459a","article-title":"A randomized phase II study of gemcitabine or paclitaxel or vinorelbine with cisplatin as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small-cell lung cancer (NSCLC) (CALGB study 9431)","volume":"18","author":"Vokes","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1008328207137_bb0105","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419550219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419550219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/11\/4\/445\/7296267\/11-4-445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:14:52Z","timestamp":1582164892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419550219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S0923753419550219"],"URL":"https:\/\/doi.org\/10.1023\/a:1008328207137","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}